Skip to main content
Kamada Ltd. logo

Kamada Ltd. — Investor Relations & Filings

Ticker · KMDA ISIN · IL0010941198 TA Manufacturing
Open in API
Filings indexed 822 across all filing types
Latest filing 2014-12-11 Report Publication Anno…
Country IL Israel
Listing TA KMDA

About Kamada Ltd.

https://www.kamada.com

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Recent filings

Filing Released Lang Actions
Immediate Report
Report Publication Announcement Classification · 1% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange. The key content is an announcement stating: 'Attached hereto is a report on *Kamada Announces Positive Interim Results from Phase I/II Clinical Study of its human Alpha-1 Antitrypsin to Treat Graft-versus-Host Disease*'. Since the document itself is short (1700 chars) and serves primarily to announce the publication of a separate, more detailed report (indicated by the attached PDF filename), it fits the definition of a Report Publication Announcement (RPA). It is not the full clinical study results (which would be IR or AR), but the announcement of those results.
2014-12-11 English
Other Report or Announcement
Regulatory Filings
2014-12-02 Hebrew (modern)
Other Report or Announcement
Regulatory Filings Classification · 1% confidence The document is very short (1588 characters) and explicitly states that an attached report is being provided. The key phrase is: "Attached hereto is a report on *Security Ownership of Certain Beneficial Owners* ficial_Owners_isa.pdf". This indicates the document's primary function is to announce the availability of another report, not to contain the full content of that report. 'Security Ownership of Certain Beneficial Owners' relates to insider holdings or major shareholder changes. Since the document is an announcement of a report about ownership/insider dealings, and it is not a standard 10-K, ER, or IR, it fits best as a general Regulatory Filing (RNS) or potentially related to Director's Dealing (DIRS) if the attached document is specifically about directors. Given the generic nature of the announcement wrapper and the reference to 'Other Report or Announcement' under Israeli regulations, RNS is the safest general classification for an announcement wrapper, although DIRS is contextually relevant to the attachment's title. However, following Rule 2 (Menu vs Meal), this is an announcement of a report, making RPA or RNS likely. Since the content is about ownership/insider activity, and RNS is the general regulatory fallback for non-standard announcements, I will use RNS, as RPA is usually for announcing the publication timing of major reports like 10-K/IR.
2014-12-02 English
Other Report or Announcement
Regulatory Filings
2014-11-18 Hebrew (modern)
Other Report or Announcement
Regulatory Filings Classification · 1% confidence The document is very short (1591 characters) and explicitly states that an 'Other Report or Announcement' is attached, specifically mentioning an 'Interest payment 2014' in a PDF file named 'KMDA_Form_6-K_-_Interest_payment_2014_isa.pdf'. The presence of 'Form 6-K' suggests a filing with the SEC, but the context here is an announcement made via the Israeli MAGNA system to the Israel Securities Authority and Tel Aviv Stock Exchange. Since the document itself is merely an announcement stating that a specific report (interest payment details) is attached, it fits the criteria for a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS) based on the 'MENU VS MEAL' rule. Given the specific nature of the attached document ('Interest payment'), it relates to financial obligations. However, none of the specific codes (like DIV for dividend) perfectly match an interest payment announcement. The most appropriate general category for a regulatory announcement that doesn't fit a specific financial event code (like DIV or CAP) and is clearly an announcement of an attached report is RNS (Regulatory Filings) or RPA (Report Publication Announcement). Since it announces the publication of a specific report ('Interest payment 2014'), RPA is slightly more precise than the general RNS fallback, although RNS is also plausible. Given the options, RNS is the safest fallback for miscellaneous regulatory announcements not covered by the specific financial event codes.
2014-11-18 English
Other Report or Announcement
Regulatory Filings
2014-11-14 Hebrew (modern)

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.